
Japan's Marubeni takes on Sumitomo's Asia pharma business to make new company in deal worth up to $480M
In the latest in a growing trend of pharma reshuffling moves in Asia, Marubeni Corporation is absorbing Sumitomo Pharma’s operations in Asia to create a new company with a share purchase agreement worth about 72 billion yen ($480 million). Japanese …